Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $14.6 million.

  • Cellebrite DI's Other Non-Current Assets rose 9028.9% to $14.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $14.6 million, marking a year-over-year increase of 9028.9%. This contributed to the annual value of $14.6 million for FY2025, which is 9028.9% up from last year.
  • Cellebrite DI's Other Non-Current Assets amounted to $14.6 million in Q4 2025, which was up 9028.9% from $6.3 million recorded in Q3 2025.
  • In the past 5 years, Cellebrite DI's Other Non-Current Assets registered a high of $14.6 million during Q4 2025, and its lowest value of $179000.0 during Q3 2021.
  • Over the past 5 years, Cellebrite DI's median Other Non-Current Assets value was $6.5 million (recorded in 2025), while the average stood at $5.3 million.
  • In the last 5 years, Cellebrite DI's Other Non-Current Assets soared by 91955.31% in 2022 and then plummeted by 1868.92% in 2025.
  • Quarter analysis of 5 years shows Cellebrite DI's Other Non-Current Assets stood at $2.0 million in 2021, then dropped by 11.59% to $1.7 million in 2022, then soared by 324.09% to $7.3 million in 2023, then rose by 4.65% to $7.7 million in 2024, then surged by 90.29% to $14.6 million in 2025.
  • Its Other Non-Current Assets was $14.6 million in Q4 2025, compared to $6.3 million in Q3 2025 and $6.7 million in Q2 2025.